StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Nuo Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.15M. For fiscal 2025 it was -$864.97K. The highest annual figure on record is -$53.82K in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$864.97K–
FY2024Dec 31, 2024-$2.23M–
FY2023Dec 31, 2023-$3.17M–
FY2022Dec 31, 2022-$3.71M–
FY2021Dec 31, 2021-$119.96K–
FY2020Dec 31, 2020-$53.82K–
FY2019Dec 31, 2019-$921.67K–
FY2018Dec 31, 2018-$874.39K–
FY2017Dec 31, 2017-$4.90M–
FY2015Dec 31, 2015-$14.39M–
FY2014Dec 31, 2014-$17.42M–
FY2013Dec 31, 2013-$11.40M–
FY2012Dec 31, 2012-$11.39M–
FY2011Dec 31, 2011-$4.24M–
FY2010Dec 31, 2010-$3.54M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$236.48K-190.1%
Q1 FY2026Mar 31, 2026-$784.27K-43073.8%
Q4 FY2025Dec 31, 2025-$422.65K–
Q3 FY2025Sep 30, 2025-$706.52K–
Q2 FY2025Jun 30, 2025$262.37K–
Q1 FY2025Mar 31, 2025$1.83K–
Q4 FY2024Dec 31, 2024-$490.54K–
Q3 FY2024Sep 30, 2024-$487.47K–
Q2 FY2024Jun 30, 2024-$691.17K–
Q1 FY2024Mar 31, 2024-$562.45K–
Q4 FY2023Dec 31, 2023-$671.41K–
Q3 FY2023Sep 30, 2023-$794.88K–
Q2 FY2023Jun 30, 2023-$905.89K–
Q1 FY2023Mar 31, 2023-$795.60K–
Q4 FY2022Dec 31, 2022-$821.69K–
Q3 FY2022Sep 30, 2022-$1.01M–
Q2 FY2022Jun 30, 2022-$1.14M–
Q1 FY2022Mar 31, 2022-$737.33K–
Q4 FY2021Dec 31, 2021-$106.95K–
Q3 FY2021Sep 30, 2021-$3.16K–
Q2 FY2021Jun 30, 2021-$5.68K–
Q1 FY2021Mar 31, 2021-$4.17K–
Q4 FY2020Dec 31, 2020-$33.57K–
Q3 FY2020Sep 30, 2020-$13-100.2%
Q2 FY2020Jun 30, 2020-$11.20K–
Q1 FY2020Mar 31, 2020-$9.04K–
Q4 FY2019Dec 31, 2019-$302.08K-178.1%
Q3 FY2019Sep 30, 2019$8.29K–
Q2 FY2019Jun 30, 2019-$176.28K–
Q1 FY2019Mar 31, 2019-$451.61K–
Q4 FY2018Dec 31, 2018$386.76K–
Q3 FY2018Sep 30, 2018-$438.92K–
Q2 FY2018Jun 30, 2018-$275.65K–
Q1 FY2018Mar 31, 2018-$546.58K–
Q4 FY2017Dec 31, 2017-$1.20M–
Q3 FY2017Sep 30, 2017-$1.41M–
Q2 FY2017Jun 30, 2017-$1.01M–
Q1 FY2017Mar 31, 2017-$1.28M–

More Nuo Therapeutics figures

See a number that looks wrong?